Stock screener
All disclosures →
EDGAR →
LGND
Conviction 80HealthcareScan · Mon, Aug 10, 2026Dragonfly doji
LGND$295.30+0.73%
ResistanceSupportVol 14Insider sellCongress buyCongress sell7
Vol MA14 296.7K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price295.30
Change+0.73%
Gap+0.81%
Rel volume0.80×
Avg volume308.62K
Avg $ vol91.83M
SMA 20297.65
SMA 50284.63
SMA 200223.66
Price vs 50+3.75%
Price vs 200+32.03%
MA stackbullish
50/200 cross—
Supertrendup · 283.22
RSI (14)50
MACD hist-1.65
MACD cross—
Stoch %K / %D34 / 37
ADX (14)15
+DI / −DI20 / 18
RSI divergence—
MACD divergenceBullish
ATR %+4.11%
ADR %3.93%
52w high322.61
52w low147.01
From 52w high-8.47%
Above 52w low+100.87%
New 52w highNo
SqueezeOn · 3d
Bollinger width6.66%
%B0.38
Donchian pos34.19%
Donchian high317.49
Donchian low283.77
AVWAP (52w high)302.16
vs AVWAP high-2.27%
AVWAP (52w low)222.00
vs AVWAP low+33.02%
OBV trendDown
Chaikin MF (20)-0.28
Today vs 20d0.80×
Avg vol (14d)296.7K
Avg vol (20d)308.62K
Avg $ vol (20d)91.83M
Market cap5.89B
RS 3m (vs SPY)+33.68%
RS 6m (vs SPY)+38.82%
RS line new highNo
Trend template8/8
Technical rank70.9
1 week+1.12%
1 month-6.62%
3 months+33.37%
6 months+55.06%
1 year+101.82%
YTD+55.33%
P/E47.30
P/B6.08
P/S21.96
P/FCF120.37
EPS6.13
Div yield—
ROE12.86%
ROA5.69%
Debt/Eq1.16
Current31.18
EV/EBITDA80.33
Gross margin—
Net margin46.42%
Rev growth60.40%
EPS growth3186.63%
Price target350.43
Target upside18.67%
Analyst ratingBuy
Institutional115.79%
Ent. value6.01B
Revenue63.69M
Net income48.51M
Gross profit—
Free cash flow48.91M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out20.04M
Employees47
ListedFri, Nov 25, 1994
Free float18.87M
Float %95.9%
Short interest1.92M
Days to cover5.0d
Short volume59.2%
Squeeze score58 / 100
Next earnings—
EPS forecast—
Last EPS vs est$2.22 vs $1.34
Last surprise+65.7% beat
Setup gradeA
Conviction80 / 100
Pattern quality—
Tech rank70.9 / 100
Group rank86 / 100 · Leading
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmDragonfly doji
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in LGND · 2 recent
Insider activity
SEC Form 4 transactions in LGND · 6 buys · 4 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Sabba Stephen L Director · Common Stock · 2026-06-16 | Exercise | 2.15K | $142K | 2026-06-16 | 2026-06-18 |
Sabba Stephen L Director · Non-Qualified Stock Option (right to buy) · 2026-06-16 | Exercise | 2.15K | — | 2026-06-16 | 2026-06-18 |
Sabba Stephen L Director · Common Stock · 2026-06-16 | Sell | 2.15K | $545K | 2026-06-16 | 2026-06-18 |
Aryeh Jason Director · Common Stock · 2026-06-11 | Sell | 4.5K | $1.1M | 2026-06-11 | 2026-06-12 |
Aryeh Jason Director · Common Stock · 2026-06-10 | Sell | 500 | $125K | 2026-06-10 | 2026-06-12 |
Aryeh Jason Director · Non-Qualified Stock Option (right to buy) · 2026-06-05 | Grant | 2.94K | — | 2026-06-05 | 2026-06-12 |
Aryeh Jason Director · Common Stock · 2026-06-05 | Grant | 836 | — | 2026-06-05 | 2026-06-12 |
LAMATTINA JOHN L Director · Non-Qualified Stock Option (right to buy) · 2026-06-05 | Grant | 2.94K | $0 | 2026-06-05 | 2026-06-09 |
KOZARICH JOHN W Director · Common Stock · 2026-06-05 | Grant | 836 | $0 | 2026-06-05 | 2026-06-09 |
LAMATTINA JOHN L Director · Common Stock · 2026-06-05 | Grant | 836 | $0 | 2026-06-05 | 2026-06-09 |
SEC filings
EDGAR filings in LGND · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.